4
Changes in Ownership
GENELUX Corp Filed Acc 0001641172-25-026397
Options or other derivatives
- SVP, Clinical Development acquired 272,652 shares (grant or award)
- SVP, Clinical Development returned 272,652 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Yu Yong · SVP, Clinical Development
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-09-01 | Returned to the company : show line 1 in the form Stock Option (Right to Buy) | −207,652 | 0 | D |
| 2025-09-01 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +207,652 | 207,652 | D |
| 2025-09-01 | Returned to the company : show line 3 in the form Stock Option (Right to Buy) | −65,000 | 0 | D |
| 2025-09-01 | Grant or award : show line 4 in the form Stock Option (Right to Buy) | +65,000 | 65,000 | D |
Loading xslF345X05/ownership.xml…